

Cover Story
Free
By Matthew Bin Han Ong and Alexandria Carolan
Global health organizations, federal health agencies, and cancer epidemiology experts say they aren't swayed by just-published recommendations on consumption of red and processed meat.
Conversation with The Cancer LetterFree
By Alexandria Carolan and Matthew Bin Han Ong
Conversation with The Cancer LetterFree
By Alexandria Carolan and Matthew Bin Han Ong
In Brief
Clinical Roundup


Drugs & Targets
NCI Trials


NCI Trials for October
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - The Galleri MCD vote: What FDA asked its advisors to ignore
- The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says














